BAM Logo

Thyroid stimulating hormone newborn screening

[CNN-2 Hormona estimulante del tiroides, cribado neonatal]

EPTIS factsheet 956103 | Last revision 2022-08-31 | URL: https://www.eptis.bam.de/pts956103 https://www.eptis.bam.de/pts956103

PT provider
PT provider Centro de Hemoterapia y Hemodonación de Castilla y León Centro de Hemoterapia y Hemodonación de Castilla y León
Based in Spain
Language(s) English, Spanish
Product groups Human test material
Testing fields Analytical chemistry
Medical analysis
Technical details
Test item Tested property Testing method
Dry blood spots TSH -
Aims of the PT scheme
Target group of participants Newborn screening labs
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants 10
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee 200 Euros
Regularly operated Yes (2 monthly)
Year of first operation 2019
Contact details of the PT provider
Provider Contact person
Centro de Hemoterapia y Hemodonación de Castilla y León
Paseo de Filipinos s/n

Phone: +34983418823
Web: https://www.controlcribado.centrodehemoterapiacyl.es https://www.controlcribado.centrodehemoterapiacyl.es
Arancha Barrera
Phone: +34983418823
Email: geclid.chem@saludcastillayleon.es geclid.chem@saludcastillayleon.es
If you find any mistakes please contact the responsible EPTIS coordinator in Spain, Mr Miquel Navarro. Mr Miquel Navarro.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.22